About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
Sustainable development/ESG“We help people live healthy lives in a healthy world”. This is our mission, which reflects Polpharma’s priorities. We provide patients with high-quality, effective, safe and accessible products while operating responsibly in the society, the environment and with respect to key stakeholders.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
The elements of the Ethics Program:The Code of EthicsInternal and external communicationEthics educationInstitutional supportViolation reporting systemPolpharma has a Compliance System which purpose is to ensure compliance with applicable regulations and voluntarily accepted obligations and to promote an organizational culture based on ethical values and standards.
The Polpharma’s Code of Ethics is a part of comprehensive Ethical Program implemented in the company to build a strong ethical culture in Polpharma. The provisions of the Code of Ethics are based on ethical values shared by employees, which include: respect, honesty, responsibility, cooperation and solidarity.The Code of Ethics represents a kind of constitution of the rights and obligations of Polpharma employees. The Code helps us deal with difficult or ethically ambiguous situations at work. It supports us in making the right decisions regardless of the nature of the job and the position we occupy.Polpharma has also implemented an important new document in Poland – the Anti-Corruption Code. It contains a set of rules and procedures designed to define standards of conduct for employees and associates of Polpharma in order to counteract corruption and its negative effects.
We believe in communication based on openness and transparency and in dialogue both within and beyond the organisation.Detailed information about our Code of Ethics and our principles is available on our intranet and in company publications. We also communicate directly by inviting our colleagues to participate in meetings at individual companies in Poland and abroad, as well as by presenting Polpharma’s good practices and experiences at external forum.
We conduct e-learning training and lectures, which have allowed us to create an organisational culture based on values that are clear for all of us.
Its fundamental purpose is, i.a. to determine ethical and legal rules of conduct in relations with:persons performing public functions,healthcare professionals,business partners (contractors, counterparties).All of our employees and associates are obliged to comply with the principles of the Anti-Corruption Code. Our business partners, cooperating with us or acting for or in our behalf, are also obliged to act lawfully and to prevent corruption by following the principles of the Code, included in the Abstract from the Anti-Corruption Code.Therefore, all our contractors and counterparties should familiarise themselves with the Abstract.The Anti-Corruption Code and the Abstract, in versions adjusted to local law requirements, apply also to the Representative Offices of the Polpharma Pharmaceutical Works.Selected principles of the Anti-Corruption Code:We always comply with the law as a matter of priority.We are bound by the ‘No tolerance for corruption’ principle.We do not offer or give gifts or benefits of any kind to public officials.We do not accept any gifts that could compromise the image of Polpharma or influence our business decisions.We avoid conflicts of interest and in case they arise, we immediately report them to the Compliance Officer.We always react when we witness behaviour contrary to Polpharma’s ethical and anti-corruption principles and applicable laws.Open the Abstract from the Anti-Corruption Code to read its contents: Abstract from the Anti-Corruption CodePolpharma obtains ISO 37001 certificationWe are pleased to announce that Polpharma has obtained certification of compliance with the international standard ISO 37001:2016 – Anti-Bribery Management Systems, which specifies requirements for the implementation, maintenance and improvement of anti-bribery management systems.The certification was carried out by an independent external audit body, Bureau Veritas, and confirms that our organization meets the highest standards in the field of anti-corruption.The certificate covers ZF Polpharma S.A. – 100% of our sites: Starogard Gdański, Warsaw, Duchnice, Sieradz, and Nowa Dęba.ISO 37001 Certyficate As part of the certification process, audits were carried out at 80% of our sites (in Starogard Gdański, Warsaw, Duchnice, and Sieradz), which allowed for a comprehensive assessment of the implemented anti-corruption management system.The ISO 37001 certificate has been granted for a specified period and will be subject to regular recertification audits. As part of the continuous improvement of the anti-corruption management system, we plan to further develop and strengthen mechanisms to prevent irregularities.Therefore, in subsequent audit cycles, we plan to cover 100% of ZF Polpharma S.A. locations, including the factory in Nowa Dęba.Obtaining the ISO 37001:2016 certificate is not only formal confirmation of compliance with the standard – it is above all an expression of our commitment to building a culture of integrity, transparency, and responsibility. The certification is the result of the systematic work of the entire Polpharma team.The ISO 37001:2016 certification marks an important milestone in strengthening our ethical culture and goes hand in hand with the Senior Management’s declaration in which Senior Management declares its full commitment to implementing, maintaining, and continuously improving an anti-corruption management system that complies with the requirements of PN-ISO 37001Open the Senior Management Declaration to read its contents (polish version only): Senior Management Declaration
The role of the Compliance Officer is to supervise the proper functioning of the Ethics Programme, to comply with the provisions of the Code of Ethics (receiving and investigating reports regarding violations of ethical principles), as well as to provide employees with advice on ethically challenging matters.The Compliance Officer also supervises all activities defined in the Polpharma Global Compliance Policy. The policy is a set of 10 principles that show how to achieve business goals in accordance with the law and the company’s values. This policy represents a comprehensive approach to managing the risk of abuse and sets standards for subsidiaries and our business partners in international markets.
In Polpharma, we have created a dedicated email address and phone number for direct contact with the Compliance Officer. Queries can also be sent via an interactive form (available to all our stakeholders).If you witness a violation, please complete the Violation Report Form.
